Fedak, Paul W M <br/><br/>
Cell therapy limits myofibroblast differentiation and structural cardiac remodeling: basic fibroblast growth factor-mediated paracrine mechanism.  [electronic resource] 

 -  Circulation. Heart failure  May 2012 
 - 349-56 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1941-3297 
<br/><br/><label>Standard No.: </label>10.1161/CIRCHEARTFAILURE.111.965889  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Actins--metabolism<br/>Animals<br/>Cell Differentiation--physiology<br/>Cell- and Tissue-Based Therapy--methods<br/>Extracellular Matrix--metabolism<br/>Fibroblast Growth Factor 2--physiology<br/>Male<br/>Matrix Metalloproteinase 2--metabolism<br/>Models, Animal<br/>Muscle, Smooth, Vascular--cytology<br/>Myocardial Contraction--physiology<br/>Myocardial Infarction--pathology<br/>Myofibroblasts--metabolism<br/>Paracrine Communication--physiology<br/>Rats<br/>Rats, Inbred F344<br/>Tissue Inhibitor of Metalloproteinase-2--metabolism<br/>Ventricular Remodeling--physiology